Literature DB >> 24269493

Artemin induced functional recovery and reinnervation after partial nerve injury.

Ruizhong Wang1, Anthony Rossomando2, Dinah W Y Sah2, Michael H Ossipov1, Tamara King1, Frank Porreca3.   

Abstract

Systemic artemin promotes regeneration of dorsal roots to the spinal cord after crush injury. However, it is unclear whether systemic artemin can also promote peripheral nerve regeneration, and functional recovery after partial lesions distal to the dorsal root ganglion (DRG) remains unknown. In the present investigation, male Sprague Dawley rats received axotomy, ligation, or crush of the L5 spinal nerve or sham surgery. Starting the day of injury, animals received intermittent subcutaneous artemin or vehicle across 2weeks. Sensory thresholds to tactile or thermal stimuli were monitored for 6weeks after injury. Immunohistochemical analyses of the DRG and nerve regeneration were performed at the 6-week time point. Artemin transiently reversed tactile and thermal hypersensitivity after axotomy, ligation, or crush injury. Thermal and tactile hypersensitivity reemerged within 1week of treatment termination. However, artemin-treated rats with nerve crush, but not axotomy or ligation, subsequently showed gradual return of sensory thresholds to preinjury baseline levels by 6weeks after injury. Artemin normalized labeling for NF200, IB4, and CGRP in nerve fibers distal to the crush injury, suggesting persistent normalization of nerve crush-induced neurochemical changes. Sciatic and intradermal administration of dextran or cholera toxin B distal to the crush injury site resulted in labeling of neuronal profiles in the L5 DRG, suggesting regeneration functional restoration of nonmyelinated and myelinated fibers across the injury site into cutaneous tissue. Artemin also diminished ATF3 and caspase 3 expression in the L5 DRG, suggesting persistent neuroprotective actions. A limited period of artemin treatment elicits disease modification by promoting sensory reinnervation of distal territories and restoring preinjury sensory thresholds.
Copyright © 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Artemin; Hyperalgesia; Peripheral nerve injury; Regeneration; Sensory neurons

Mesh:

Substances:

Year:  2013        PMID: 24269493      PMCID: PMC3936608          DOI: 10.1016/j.pain.2013.11.007

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  27 in total

1.  GDNF and NGF family members and receptors in human fetal and adult spinal cord and dorsal root ganglia.

Authors:  A Josephson; J Widenfalk; A Trifunovski; H R Widmer; L Olson; C Spenger
Journal:  J Comp Neurol       Date:  2001-11-12       Impact factor: 3.215

2.  GFRalpha3 is expressed predominantly in nociceptive sensory neurons.

Authors:  O E Orozco; L Walus; D W Sah; R B Pepinsky; M Sanicola
Journal:  Eur J Neurosci       Date:  2001-06       Impact factor: 3.386

3.  Selective mediation of nerve injury-induced tactile hypersensitivity by neuropeptide Y.

Authors:  Michael H Ossipov; En-Tan Zhang; Cristina Carvajal; Luis Gardell; Remi Quirion; Yvan Dumont; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

4.  Potent analgesic effects of GDNF in neuropathic pain states.

Authors:  T J Boucher; K Okuse; D L Bennett; J B Munson; J N Wood; S B McMahon
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

5.  Redistribution of Na(V)1.8 in uninjured axons enables neuropathic pain.

Authors:  Michael S Gold; Daniel Weinreich; Chang-Sook Kim; Ruizhong Wang; James Treanor; Frank Porreca; Josephine Lai
Journal:  J Neurosci       Date:  2003-01-01       Impact factor: 6.167

6.  Descending facilitation maintains long-term spontaneous neuropathic pain.

Authors:  Ruizhong Wang; Tamara King; Milena De Felice; Wenhong Guo; Michael H Ossipov; Frank Porreca
Journal:  J Pain       Date:  2013-04-19       Impact factor: 5.820

7.  The glial cell line-derived neurotrophic factor family receptor components are differentially regulated within sensory neurons after nerve injury.

Authors:  D L Bennett; T J Boucher; M P Armanini; K T Poulsen; G J Michael; J V Priestley; H S Phillips; S B McMahon; D L Shelton
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

8.  Inhibition of neuropathic pain by decreased expression of the tetrodotoxin-resistant sodium channel, NaV1.8.

Authors:  Josephine Lai; Michael S Gold; Chang Sook Kim; Di Bian; Michael H Ossipov; John C Hunter; Frank Porreca
Journal:  Pain       Date:  2002-01       Impact factor: 6.961

9.  Characterisation of the human GFRalpha-3 locus and investigation of the gene in Hirschsprung disease.

Authors:  C I Onochie; L M Korngut; J B Vanhorne; S M Myers; D Michaud; L M Mulligan
Journal:  J Med Genet       Date:  2000-09       Impact factor: 6.318

10.  Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD.

Authors:  J G Nutt; K J Burchiel; C L Comella; J Jankovic; A E Lang; E R Laws; A M Lozano; R D Penn; R K Simpson; M Stacy; G F Wooten
Journal:  Neurology       Date:  2003-01-14       Impact factor: 9.910

View more
  14 in total

1.  c-Jun gene-modified Schwann cells: upregulating multiple neurotrophic factors and promoting neurite outgrowth.

Authors:  Liangliang Huang; Xin Quan; Zhongyang Liu; Teng Ma; Yazhen Wu; Jun Ge; Shu Zhu; Yafeng Yang; Liang Liu; Zhen Sun; Jinghui Huang; Zhuojing Luo
Journal:  Tissue Eng Part A       Date:  2015-04       Impact factor: 3.845

2.  Ablation of sensory neurons in a genetic model of pancreatic ductal adenocarcinoma slows initiation and progression of cancer.

Authors:  Jami L Saloman; Kathryn M Albers; Dongjun Li; Douglas J Hartman; Howard C Crawford; Emily A Muha; Andrew D Rhim; Brian M Davis
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

3.  Characterization of axons expressing the artemin receptor in the female rat urinary bladder: a comparison with other major neuronal populations.

Authors:  Shelley L Forrest; Peregrine B Osborne; Janet R Keast
Journal:  J Comp Neurol       Date:  2014-07-24       Impact factor: 3.215

4.  Pharmacokinetics and pharmacodynamics of multiple doses of BG00010, a neurotrophic factor with anti-hyperalgesic effects, in patients with sciatica.

Authors:  Pieter Okkerse; Justin L Hay; Eve Versage; Yongqiang Tang; Gerald Galluppi; Bernard Ravina; Ajay Verma; Leslie Williams; Ernesto Aycardi; Geert Jan Groeneveld
Journal:  Br J Clin Pharmacol       Date:  2016-05-13       Impact factor: 4.335

5.  Artemin promotes functional long-distance axonal regeneration to the brainstem after dorsal root crush.

Authors:  Laura Elisabeth Wong; Molly E Gibson; H Moore Arnold; Blake Pepinsky; Eric Frank
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-27       Impact factor: 11.205

6.  Peripherally increased artemin is a key regulator of TRPA1/V1 expression in primary afferent neurons.

Authors:  Yasuko Ikeda-Miyagawa; Kimiko Kobayashi; Hiroki Yamanaka; Masamichi Okubo; Shenglan Wang; Yi Dai; Hideshi Yagi; Munetaka Hirose; Koichi Noguchi
Journal:  Mol Pain       Date:  2015-03-08       Impact factor: 3.395

7.  Femoral nerve regeneration and its accuracy under different injury mechanisms.

Authors:  Qiang Ao; Yu Wang; Peng Cao; Jiang Peng
Journal:  Neural Regen Res       Date:  2015-10       Impact factor: 5.135

8.  A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat.

Authors:  Yulia A Sidorova; Maxim M Bespalov; Agnes W Wong; Oleg Kambur; Viljami Jokinen; Tuomas O Lilius; Ilida Suleymanova; Gunnar Karelson; Pekka V Rauhala; Mati Karelson; Peregrine B Osborne; Janet R Keast; Eija A Kalso; Mart Saarma
Journal:  Front Pharmacol       Date:  2017-06-21       Impact factor: 5.810

9.  Ultrasound imaging of chitosan nerve conduits that bridge sciatic nerve defects in rats.

Authors:  Xiaoyang Chen; Yifei Yin; Tingting Zhang; Yahong Zhao; Yumin Yang; Xiaomei Yu; Hongkui Wang
Journal:  Neural Regen Res       Date:  2014-07-15       Impact factor: 5.135

10.  Novel RET agonist for the treatment of experimental neuropathies.

Authors:  Hanna Viisanen; Ulpukka Nuotio; Oleg Kambur; Arun Kumar Mahato; Viljami Jokinen; Tuomas Lilius; Wei Li; Hélder A Santos; Mati Karelson; Pekka Rauhala; Eija Kalso; Yulia A Sidorova
Journal:  Mol Pain       Date:  2020 Jan-Dec       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.